Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price traded up 0.8% on Monday . The company traded as high as $1.87 and last traded at $1.84. 13,345,254 shares changed hands during trading, a decline of 54% from the average session volume of 29,081,066 shares. The stock had previously closed at $1.82.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. CIBC dropped their target price on shares of Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a report on Wednesday, April 10th. Canaccord Genuity Group dropped their price objective on shares of Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners increased their price objective on shares of Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a report on Friday, April 5th.
Read Our Latest Analysis on TLRY
Tilray Stock Performance
The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The stock's fifty day moving average is $1.97 and its two-hundred day moving average is $1.97. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -4.05 and a beta of 2.36.
Hedge Funds Weigh In On Tilray
Large investors have recently bought and sold shares of the stock. Macquarie Group Ltd. increased its stake in Tilray by 188.8% during the 2nd quarter. Macquarie Group Ltd. now owns 8,540 shares of the company's stock valued at $27,000 after buying an additional 5,583 shares during the period. Cetera Advisor Networks LLC acquired a new position in Tilray during the 1st quarter valued at about $82,000. Clear Street Markets LLC acquired a new position in Tilray during the 3rd quarter valued at about $25,000. Kingsview Wealth Management LLC acquired a new position in Tilray during the 2nd quarter valued at about $33,000. Finally, Squarepoint Ops LLC acquired a new position in Tilray during the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
